Drug Delivery Methods and Systems Patent

ChangeBridge: EPO Bulletin - Medical Devices (A61M)

Published March 25th, 2026

Detected April 1st, 2026

Summary

The European Patent Office published patent application EP3801732A1 for drug delivery methods and systems, filed by Morningside Venture Investments Limited. The patent covers physical drug delivery technologies classified under A61M and has been designated for validation across 32 European Patent Convention member states including Germany, France, UK, Italy, Spain, and the Netherlands.

View original document View source feed page

What changed

EPO published patent EP3801732A1 titled 'Drug Delivery Methods and Systems' on March 25, 2026. The patent application, filed by Morningside Venture Investments Limited with inventors Tong Ling-Kang, Buchman Daniela Tamar, Hancock Jackie Joe, and Terzulli Nicholas, covers drug delivery technologies classified under IPC A61M 35/00. The application has been designated for validation across 32 European Patent Convention contracting states.

This is a patent publication rather than a regulatory requirement, imposing no compliance obligations on third parties. Companies developing drug delivery devices or systems should review the patent claims to assess potential infringement risks before commercializing similar technologies in EPO member states.

Source document (simplified)

← EPO Patent Bulletin

DRUG DELIVERY METHODS AND SYSTEMS

Publication EP3801732A1 Kind: A1 Mar 25, 2026

Applicants

Morningside Venture Investments Limited

Inventors

TONG, Ling-Kang, BUCHMAN, Daniela, Tamar, HANCOCK, Jackie, Joe, TERZULLI, Nicholas

IPC Classifications

A61M 35/00 20060101AFI20220322BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →